PTJ
INO icon

Paul Tudor Jones’s Inovio Pharmaceuticals INO Stock Holding History

Paul Tudor Jones’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,235
Closed -$68.8K – 2471
2023
Q4 		$68.8K Sell
11,235
-7,600
-40% -$37.5K ﹤0.01% 2260
2023
Q3 		$87.9K Sell
18,835
-27,289
-59% -$151K ﹤0.01% 2157
2023
Q2 		$247K Buy
46,124
+34,889
+311% +$281K ﹤0.01% 2111
2023
Q1 		$111K Sell
11,235
-381
-3% -$6.5K ﹤0.01% 2249
2022
Q4 		$217K Buy
+11,616
New +$263K ﹤0.01% 2098
2022
Q3 		– Sell
-16,378
Closed -$340K – 2500
2022
Q2 		$340K Buy
16,378
+12,233
+295% +$345K 0.01% 1487
2022
Q1 		$179K Sell
4,145
-22,852
-85% -$1.03M ﹤0.01% 1789
2021
Q4 		$1.62M Buy
26,997
+4,176
+18% +$335K 0.03% 749
2021
Q3 		$1.96M Buy
22,821
+14,511
+175% +$1.46M 0.03% 723
2021
Q2 		$924K Buy
+8,310
New +$798K 0.02% 899
2020
Q4 		– Sell
-1,692
Closed -$235K – 1459
2020
Q3 		$235K Buy
1,692
+218
+15% +$45.5K 0.01% 1086
2020
Q2 		$477K Sell
1,474
-419
-22% -$67.3K 0.02% 742
2020
Q1 		$169K Buy
+1,893
New +$117K 0.02% 860
2017
Q4 		– Sell
-4,167
Closed -$317K – 1160
2017
Q3 		$317K Buy
+4,167
New +$310K 0.01% 811
2016
Q3 		– Sell
-2,233
Closed -$248K – 1562
2016
Q2 		$248K Sell
2,233
-1,959
-47% -$238K 0.01% 1282
2016
Q1 		$438K Buy
+4,192
New +$324K 0.01% 1040
2015
Q4 		– Sell
-1,260
Closed -$87K – 1741
2015
Q3 		$87K Buy
+1,260
New +$110K ﹤0.01% 1439
2014
Q4 		– Sell
-1,018
Closed -$120K – 1524
2014
Q3 		$120K Buy
+1,018
New +$127K ﹤0.01% 1266
2014
Q2 		– Sell
-648
Closed -$104K – 1238
2014
Q1 		$104K Buy
+648
New +$93K ﹤0.01% 1120

Other funds holding INO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Paul Tudor Jones's INO Position: Q1 2024 in Review

Paul Tudor Jones sold out of Inovio Pharmaceuticals (INO) in Q1 2024, closing a stake of 11,235 shares — an estimated $68.8K sold.

Paul Tudor Jones first reported a position in INO in Q1 2014 and held it in 19 quarters. The position peaked at $1.96M in Q3 2021. 89 funds tracked by Wall St. Rank hold INO as of Q1 2024.

  • Paul Tudor Jones reported no remaining Inovio Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Paul Tudor Jones sold 11,235 Inovio Pharmaceuticals shares in Q1 2024, an estimated $68.8K.
  • Paul Tudor Jones first reported a position in Inovio Pharmaceuticals in Q1 2014 and held it in 19 quarters.
  • Paul Tudor Jones's Inovio Pharmaceuticals position peaked at $1.96M in Q3 2021.
  • 89 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q1 2024.

Based on Tudor Investment Corp's 13F filing for Q1 2024, filed 15 May 2024.